marimastat has been researched along with dalteparin in 2 studies
| Studies (marimastat) | Trials (marimastat) | Recent Studies (post-2010) (marimastat) | Studies (dalteparin) | Trials (dalteparin) | Recent Studies (post-2010) (dalteparin) |
|---|---|---|---|---|---|
| 215 | 28 | 53 | 5,665 | 1,423 | 2,267 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balkwill, F; Blann, AD; Caine, GJ; Christodoulos, K; Dobbs, N; Ganesan, TS; Gompertz, N; Harris, AL; Jones, PH; Kakkar, AJ; Kumar, S; Talbot, DC; Thavasu, P | 1 |
| Blann, AD; Caine, GJ; Christodoulos, K; Harris, AL; Lip, GY | 1 |
1 trial(s) available for marimastat and dalteparin
| Article | Year |
|---|---|
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Dalteparin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fibrinolytic Agents; Humans; Hydroxamic Acids; Injections, Subcutaneous; Lymphocytes; Male; Middle Aged; Neoplasms; Phytohemagglutinins; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
1 other study(ies) available for marimastat and dalteparin
| Article | Year |
|---|---|
Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anticoagulants; Captopril; Dalteparin; Female; Humans; Hydroxamic Acids; Male; Middle Aged; Neoplasms; Neovascularization, Pathologic; P-Selectin; Platelet Activation; Thromboplastin; Vascular Endothelial Growth Factor A | 2005 |